RGLS
Regulus Therapeutics
RGLS
RGLS
Delisted
RGLS was delisted on the 24th of June, 2025.
46 hedge funds and large institutions have $34.2M invested in Regulus Therapeutics in 2018 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 11 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
45% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 11
Holders
46
Holding in Top 10
–
Calls
$8K
Puts
–
Top Buyers
| 1 | +$44K | |
| 2 | +$35.6K | |
| 3 | +$13K | |
| 4 |
Goldman Sachs
New York
|
+$11K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$10K |
Top Sellers
| 1 | -$191K | |
| 2 | -$147K | |
| 3 | -$129K | |
| 4 |
ARTA
A.R.T. Advisors
New York
|
-$87.5K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$85.2K |